Stocks and InvestingStocks and Investing
Fri, September 15, 2023
Thu, September 14, 2023
Wed, September 13, 2023

Liisa Bayko Maintained (AKRO) at Buy with Increased Target to $60 on, Sep 13th, 2023


Published on 2024-10-28 06:24:07 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Akero Therapeutics, Inc." (AKRO) at Buy with Increased Target from $50 to $60 on, Sep 13th, 2023.

Liisa has made no other calls on AKRO in the last 4 months.



There are 5 other peers that have a rating on AKRO. Out of the 5 peers that are also analyzing AKRO, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Liisa


  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $62 on, Tuesday, September 5th, 2023
  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $83 on, Monday, August 28th, 2023
  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Monday, June 12th, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Wednesday, June 7th, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, May 17th, 2023